Dr. Ignacio Amat Santos | Innovative Leadership | Best Researcher Award
University Clinic Hospital of Valladolid, Spain
Profile
📚Early Academic Pursuits
Dr. Ignacio J. Amat-Santos embarked on his medical journey with a strong foundation in cardiology and statistical research. He completed his cardiology training at the University Clinical Hospital of Valladolid in Spain, a prestigious institution known for its rigorous medical programs. During his training, he further enriched his expertise with an external stay at Klinikum Großhadern in Munich, Germany, where he gained invaluable international experience in advanced cardiac care.
Recognizing the importance of a multidisciplinary approach in medical research, Dr. Amat-Santos pursued a degree in statistics applied to biosanitary research from the Autonoma University in Barcelona, Spain. This unique combination of clinical and statistical expertise laid the groundwork for his future contributions to cardiology and medical research.
🏥Professional Endeavors
Dr. Amat-Santos’ professional journey is marked by extensive training and practical experience in interventional cardiology. He honed his skills at the Quebec Heart & Lung Institute in Canada, one of the leading centers for cardiac care. His quest for excellence in clinical research led him to the Instituto de Salud Carlos III in Madrid, Spain, where he secured the competitive “Rio Hortega” contract. This opportunity allowed him to delve deeply into clinical research, culminating in his PhD, which was awarded the first national prize, a testament to his exceptional academic and research capabilities.
Currently, Dr. Amat-Santos serves as the Director of the Interventional Cardiology Department at the University Clinical Hospital of Valladolid, one of Spain’s largest and most renowned hospitals. In this role, he oversees a team of skilled professionals, ensuring the highest standards of cardiac care for patients.
🔬Contributions and Research Focus
Dr. Amat-Santos has made significant contributions to the field of cardiology, particularly in the area of structural cardiac interventions. He is recognized as a key opinion leader in this domain, serving as a proctor for Transcatheter Aortic Valve Implantation (TAVI) as well as for tricuspid and mitral therapies. His expertise extends to complex coronary cases, where he acts as a proctor for chronic total occlusions.
Throughout his career, Dr. Amat-Santos has been the principal investigator in over 100 studies and has authored more than 300 scientific articles. His research has been published in prestigious journals such as The Lancet, New England Journal of Medicine, JACC Cardiovascular Interventions, and EuroIntervention. Some of his notable publications include:
- Baumbach A, van Royen N, Amat-Santos IJ, et al. “LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial.” The Lancet. 2024.
- Biscaglia S, Guiducci V, Escaned J, et al; FIRE Trial Investigators. “Complete or Culprit-Only PCI in Older Patients with Myocardial Infarction.” N Engl J Med. 2023.
- Amat-Santos IJ, Estevez-Loureiro R, Sánchez-Recalde Á, et al. “Right heart remodelling after bicaval TricValve implantation in patients with severe tricuspid regurgitation.” EuroIntervention. 2023.
🏅Accolades and Recognition
Dr. Amat-Santos’ excellence in cardiology and research has been recognized through numerous accolades and awards. His PhD was awarded the first national prize, highlighting his outstanding research contributions. He is frequently invited to speak at international conferences and serves as an editor and author of several influential books in the field of cardiology.
His role as a professor of medicine at the University of Valladolid allows him to shape the next generation of cardiologists and researchers. He supervises several PhD projects, guiding students through their academic and research endeavors.
🌍Impact and Influence
Dr. Amat-Santos’ impact on the field of cardiology extends beyond his clinical and research contributions. As a proctor for TAVI and other structural cardiac interventions, he plays a crucial role in training and mentoring other cardiologists worldwide. His expertise in complex coronary cases has led to advancements in the treatment of chronic total occlusions, improving patient outcomes.
His extensive publication record and involvement in over 100 studies demonstrate his commitment to advancing medical knowledge and improving patient care. His work on prosthetic valve endocarditis, commissural alignment in TAVR, and other critical areas of cardiology has influenced clinical practices and guidelines.
🌟Legacy and Future Contributions
Dr. Amat-Santos’ legacy is characterized by his dedication to advancing the field of cardiology through research, education, and clinical practice. His contributions have significantly impacted the treatment of structural heart diseases and complex coronary conditions. As he continues to lead the Interventional Cardiology Department at the University Clinical Hospital of Valladolid, his influence on the field is poised to grow.
Looking ahead, Dr. Amat-Santos is likely to continue making groundbreaking contributions to cardiology. His ongoing research, mentorship of young cardiologists, and leadership in clinical practice ensure that his impact will be felt for years to come. His commitment to excellence and innovation in cardiology sets a high standard for future generations, cementing his legacy as a pioneer in the field.
Publications
- ESTUDIO DE FLUJO AÓRTICO TRAS IMPLANTE DE PRÓTESIS DE VÁLVULA AÓRTICA TRANSCATÉTER EN FUNCIÓN DE LA ORIENTACIÓN DE LA PRÓTESIS. DISEÑO Y VALIDACIÓN DE SIMULACIÓN COMPUTACIONAL
- Duration: 2024-01 to 2025-12
- Granting Agency: Instituto de Salud Carlos III (Valladolid, ES)
- Grant Number: DTS23/00127
- Authors: TBD
- Journal: TBD
- Year: 2024
2. Implante de prótesis aórtica transcatéter para el tratamiento de prótesis mecánica aórtica disfuncionante: Estudio translacional de prueba de concepto. (TAMEC Study)
- Duration: 2024-01 to 2024-12
- Granting Agency: GERENCIA REGIONAL DE SALUD DE CASTILLA Y LEON (Valladolid, ES)
- Grant Number: GRS 2917/A1/2023
- Authors: TBD
- Year: 2024
3. Estudio COMPLETE-2. Ensayo aleatorizado de estrategias de revascularización completa de lesiones no culpables guiadas por fisiología frente a estrategias de revascularización completa de lesiones no culpables guiadas por angiografía en pacientes con infarto agudo de miocardio y enfermedad coronaria multivaso
- Duration: 2024 to present
- Granting Agency: Canadian Institutes of Health Research y Abbott Medical Canada Co. (., CA)
- Grant Number: NCT05701358
- Authors: TBD
- Journal: TBD
- Year: 2024
4. Estudio COPERNICAN. REDUCED STENT STRATEGY VERSUS CONVENTIONAL PERCUTANEOUS CORONARY REVASCULARIZATION IN PATIENTS PRESENTING WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
- Duration: 2024 to present
- Granting Agency: Fundación para la Investigación del Hospital Universitari La Fe (Valencia, ES)
- Grant Number: NCT06353594
- Authors: TBD
- Journal: TBD
- Year: 2024
5. Estudio CROSS. Registro prospectivo de la disrupcion de guías y microcatéteres coronarios en la ICP de lesiones crónicas totales ocluidas: El ESTUDIO CROSS
- Duration: 2024 to present
- Granting Agency: ICICOR (., ES)
- Grant Number: NCT06353594
- Authors: TBD